We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$27.2B
1-Year Est. Return
43.16%
This Fund
S&P 500
This Quarter
Est. Return
+26.89%
1 Year Est. Return
+43.16%
3 Year Est. Return
+177.72%
5 Year Est. Return
+262.7%
10 Year Est. Return
+1,121.27%
AUM
$20.8B
AUM Growth
+$4.96B
(+31%)
Cap. Flow
+$1.12B
Cap. Flow
% of AUM
5.41%
Top 10 Holdings %
Top 10 Hldgs %
27.86%
Holding
1,558
New
230
Increased
644
Reduced
511
Closed
111
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$93.6M |
| 2 |
Humana
HUM
|
+$63.1M |
| 3 |
Amazon
AMZN
|
+$62.2M |
| 4 |
AbbVie
ABBV
|
+$56M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$52M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Incyte
INCY
|
+$85.1M |
| 2 |
TJX Companies
TJX
|
+$63.8M |
| 3 |
Starbucks
SBUX
|
+$58.1M |
| 4 |
Cadence Design Systems
CDNS
|
+$56.8M |
| 5 |
American Tower
AMT
|
+$47.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.15% |
| 2 | Healthcare | 14.99% |
| 3 | Consumer Discretionary | 12.14% |
| 4 | Financials | 11.31% |
| 5 | Communication Services | 8.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Puma Biotechnology
PBYI
$458M
| $812K | ﹤0.01% |
77,816
+11,955
| +18% | +$124K |
|
|
EFOR
927
Everforth Inc
EFOR
$1.32B
| $805K | ﹤0.01% |
12,066
-12,833
| -52% | -$681K |
|
|
ACRE
928
Ares Commercial Real Estate
ACRE
$263M
| $804K | ﹤0.01% |
88,150
+35,440
| +67% | +$276K |
|
929
Bank of Marin Bancorp
BMRC
$465M
| $803K | ﹤0.01% |
24,099
+13,709
| +132% | +$434K |
|
930
Napco Security Technologies
NSSC
$1.37B
| $802K | ﹤0.01% |
68,600
+29,460
| +75% | +$309K |
|
931
PENN Entertainment
PENN
$2.52B
| $802K | ﹤0.01% |
26,265
-148,778
| -85% | -$3.41M |
|
932
CytomX Therapeutics
CTMX
$736M
| $801K | ﹤0.01% |
96,164
+57,500
| +149% | +$534K |
|
933
PACCAR
PCAR
$68.3B
| $799K | ﹤0.01% |
16,005
| – | – |
|
|
BRKL
934
DELISTED
Brookline Bancorp
BRKL
| $796K | ﹤0.01% |
78,967
-36,500
| -32% | -$364K |
|
935
Collegium Pharmaceutical
COLL
$914M
| $796K | ﹤0.01% |
45,476
+8,116
| +22% | +$159K |
|
936
Commercial Metals
CMC
$8.03B
| $789K | ﹤0.01% |
38,685
-360
| -0.9% | -$6.17K |
|
|
GOOD
937
Gladstone Commercial Corp
GOOD
$637M
| $789K | ﹤0.01% |
42,080
+26,970
| +178% | +$442K |
|
|
CHUY
938
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $789K | ﹤0.01% |
53,005
+13,335
| +34% | +$200K |
|
|
RVI
939
DELISTED
Retail Value Inc. Common Shares
RVI
| $789K | ﹤0.01% |
695,510
+236,343
| +51% | +$268K |
|
940
KBR
KBR
$4.71B
| $787K | ﹤0.01% |
34,890
-350
| -1% | -$7.61K |
|
941
Royal Caribbean
RCL
$83.2B
| $783K | ﹤0.01% |
+15,559
| New | +$704K |
|
942
Central Pacific Financial
CPF
$1.01B
| $779K | ﹤0.01% |
48,620
+15,553
| +47% | +$247K |
|
|
EIGI
943
DELISTED
Endurance International Group Holdings, Inc.
EIGI
| $779K | ﹤0.01% |
193,271
+80,157
| +71% | +$237K |
|
|
EIGR
944
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $778K | ﹤0.01% |
2,701
+743
| +38% | +$219K |
|
|
SRDX
945
DELISTED
Surmodics
SRDX
| $775K | ﹤0.01% |
17,923
+10,433
| +139% | +$395K |
|
|
CURO
946
DELISTED
CURO Group Holdings Corp.
CURO
| $773K | ﹤0.01% |
94,623
+15,830
| +20% | +$113K |
|
947
Iovance Biotherapeutics
IOVA
$2.92B
| $771K | ﹤0.01% |
28,101
+5,855
| +26% | +$192K |
|
|
MRSN
948
DELISTED
Mersana Therapeutics
MRSN
| $768K | ﹤0.01% |
1,314
+418
| +47% | +$143K |
|
949
Digi International
DGII
$3.21B
| $761K | ﹤0.01% |
65,294
+24,726
| +61% | +$264K |
|
950
Advance Auto Parts
AAP
$3.39B
| $760K | ﹤0.01% |
5,338
+5
| +0.1% | +$636 |
|
Similar funds
FDCDDQ
TWC
WP
N
PCH
VAI
Los Angeles Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Los Angeles Capital Management held 1,558 positions worth $20.8B, up 31% from $15.8B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Los Angeles Capital Management deployed $1.12B of net new capital in Q2 2020, opening 230 new positions and adding to 644 existing holdings. Its largest new stake was Workday: 145,773 shares worth $27.3M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Incyte, an estimated $85.1M trimmed.
- Los Angeles Capital Management's largest Q2 2020 buy was Workday: 145,773 shares worth $27.3M.
- Los Angeles Capital Management added most to Meta Platforms (Facebook) in Q2 2020, an estimated $93.6M increase.
- Los Angeles Capital Management's biggest Q2 2020 reduction was Incyte, cutting an estimated $85.1M.
- Los Angeles Capital Management fully exited Raytheon Company in Q2 2020, selling an estimated $4.93M.
- Los Angeles Capital Management's ten largest holdings make up 28% of its $20.8B portfolio in Q2 2020.
- Los Angeles Capital Management opened 230 new positions and closed 111 in Q2 2020.
- Los Angeles Capital Management's portfolio value rose 31% quarter-over-quarter to $20.8B.
Based on Los Angeles Capital Management's 13F filing for Q2 2020, filed 5 Aug 2020.